Vantive Health LLC
Quick facts
Marketed products
Phase 3 pipeline
- Dianeal, Extraneal, Nutrineal · Nephrology / Renal replacement therapy
These are peritoneal dialysis solutions that facilitate fluid and solute exchange across the peritoneal membrane to remove waste products and excess water from the blood in patients with kidney failure. - Experimental Peritoneal Dialysis Solution · Nephrology
An experimental peritoneal dialysis solution designed to improve solute clearance and fluid removal in patients with end-stage renal disease undergoing peritoneal dialysis. - Prismocitrate 18 · Nephrology / Critical Care
Prismocitrate 18 is a citrate-based anticoagulant used in regional citrate anticoagulation (RCA) for extracorporeal therapies.
Phase 2 pipeline
- Biphozyl · Other
- Prismasol 2
- Regiocit · Other
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about Vantive Health LLC
What are Vantive Health LLC's marketed drugs?
Top marketed products include Dianeal, Extraneal, Nutrineal.
What is Vantive Health LLC's pipeline?
Vantive Health LLC has 3 drugs in Phase 3, 3 in Phase 2, 0 in Phase 1. Late-stage candidates include Dianeal, Extraneal, Nutrineal, Experimental Peritoneal Dialysis Solution, Prismocitrate 18.
Related
- Dianeal · Other
- Extraneal · Other
- Nutrineal · Other
- Sector hub: All tracked pharma companies